Quick Answer
Summit Therapeutics Inc. reported Total Assets of $751.18 million for fiscal year 2025.
Summit Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $751.18M | +72.5% |
| 2024 | $435.56M | +114.6% |
| 2023 | $202.95M | -69.4% |
| 2022 | $664.17M | +485.8% |
| 2021 | $113.37M | +10.6% |
| 2020 | $102.50M | +6.5% |
| 2019 | $96.25M | +58.7% |
| 2019 | $60.63M | +9.9% |
| 2018 | $55.17M | +46.8% |
| 2017 | $37.59M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $261.73M | -48.0% | -19.2% |
| June 30, 2025 | $324.04M | -5.2% | -15.6% |
| March 31, 2025 | $383.82M | +117.1% | -11.9% |
| December 31, 2024 | $435.56M | +114.6% | -13.4% |
| September 30, 2024 | $502.85M | +130.2% | +47.1% |
| June 30, 2024 | $341.86M | +44.0% | +93.4% |
| March 31, 2024 | $176.78M | -30.6% | -12.9% |
| December 31, 2023 | $202.95M | -69.4% | -7.1% |
- Summit Therapeutics Inc. showed an increase of +72.5% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Summit Therapeutics Inc.’s total assets has grown by 1898.5% (from $37.59 million to $751.18 million).
- The most recent figure is from Summit Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: